Pyrrolidine dithiocarbamate induces cyclooxygenase-2 expression in NIH 3T3 fibroblast cells

Biochemical and Biophysical Research Communications

Volumn 298, Issue 2, 2002, Pages 230-234

  Lee, Jeong Eun ^a   Kim, Kyung Min ^a   Cho, Jae We ^b   Suh, Seong Il ^a   Suh, Min Ho ^a   Kwon, Taeg Kyu ^a   Park, Jong Wook ^a   Bae, Jae Hoon ^a   Song, Dae Kyu ^a   Cho, Chi Heum ^a   Bae, Insoo ^c   Baek, Won Ki ^a  

^a Keimyung University School of Medicine   (South Korea)

^b Seonam University   (South Korea)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Copper; Cyclooxygenase 2; Fibroblast; Pro oxidant; Pyrrolidine dithiocarbamate

Indexed keywords

CATHOCUPROLINE DISULFONIC ACID; CHELATING AGENT; COPPER; COPPER ION; CYCLOOXYGENASE 2; OXIDIZING AGENT; PYRROLIDINE DITHIOCARBAMATE; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ASSAY; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME INDUCTION; FIBROBLAST; INCUBATION TIME; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

3T3 CELLS; ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; CHELATING AGENTS; COPPER; CYCLOOXYGENASE 2; DINOPROSTONE; DITHIOTHREITOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; GENE EXPRESSION REGULATION; ISOENZYMES; KINETICS; METALS; MICE; OXIDANTS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRROLIDINES; RNA, MESSENGER; THIOCARBAMATES;

EID: 18644380648     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02430-0     Document Type: Article

References (30)

1. W.L. Smith, R.M. Garavito, D.L. DeWitt, Prostaglandin endo-peroxide H synthases (cyclooxygenases)-1 and -2, J. Biol. Chem. 271 (1996) 33157-33160.
2. J.R. Vane, Y.S. Bakhle, R.M. Botting, Cyclooxygenases 1 and 2, Annu. Rev. Pharmacol. Toxicol. 38 (1998) 97-120.
3. R.N. Dubois, S.B. Abramson, L. Crofford, R.A. Gupta, L.S. Simon, L.B.A. Van De Putte, P.E. Lipsky, Cyclooxygenase in biology and disease, FASEB J. 12 (1998) 1063-1073.
4. D.L. Dewitt, Prostaglandin endoperoxide synthase: Regulation of enzyme expression, Biochim. Biophys. Acta 1083 (1991) 121-134.
5. V.L. Marcheselli, N.G. Bazan, Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus. Inhibition by a platelet-activating factor antagonist, J. Biol. Chem. 271 (1996) 24794-24799.
6. S.M. Prescott, F.A. Fitzpatrick, Cyclooxygenase-2 and carcinogenesis, Biochim. Biophys. Acta 1470 (2000) M69-M78.
7. D. Clemett, K.L. Goa, Celecoxib: A review of its use in osteoarthritis, rheumatoid arthritis, and acute pain, Drugs 59 (2000) 957-980.
8. World Health Organization (WHO), Dithiocarbamate pesticides, ethylenethiourea, and propylenethiourea: A general introduction, Environ. Health Criter. 78 (1988) 15-31.
9. G.D. Thorn, R.A. Ludwig, The Dithiocarbamates and Related Compounds, Elsevier, Amsterdam, 1962.
10. F.W. Sunderman, Chelation therapy in nickel poisoning, Ann. Clin. Lab. Sci. 11 (1981) 1-8.
11. J.M. Lang, C. Trepo, M. Kirstetter, L. Herviou, G. Retornz, G. Renoux, M. Musset, J.L. Tourainem, P. Choutet, A. Falkenrod, J.M. Liverozet, F. Touraine, J. Caraux, Randomized, double-blind, placebo-controlled trial of dithiocarb sodium (Imuthiol) in human immunodeficiency virus infection, Lancet 2 (1988) 702-706.
12. R.J. Topping, M.M. Jones, Optimal dithiocarbamate structure for immunomodulator action, Med. Hypotheses 27 (1988) 55-57.
13. R. Bessho, K. Matsubara, M. Kubota, K. Kuwakado, H. Hirota, Y. Wakazono, Y.W. Lin, A. Okuda, M. Kawai, R. Nishikomori, T. Heike, Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor κB (NF-κB) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes, Biochem. Pharmacol. 48 (1994) 1883-1889.
14. S. Verhaegen, A.J. McGowan, A.R. Brophy, R.S. Fernandes, T.G. Cotter, Inhibition of apoptosis by antioxidants in the human HL-60 leukemia cell line, Biochem. Pharmacol. 50 (1995) 1021-1029.
15. A.B. Nathens, R. Bitar, C. Davreux, M. Bujard, J.C. Marshall, A.P.B. Dackiw, R.W.G. Watson, O.D. Rotstein, Pyrrolidine dithiocarbamate attenuates endotoxin-induced acute lung injury, Am. J. Respir. Cell Mol. Biol. 17 (1997) 608-616.
16. C.S.I. Nobel, M. Kimland, B. Lind, S. Orrenius, A.F.G. Slater, Dithiocarbamates induce apoptosis in thymocytes by raising the intracellular level of redox-active copper, J. Biol. Chem. 270 (1995) 26202-26208.
17. 2+ complex in the cultured rat cortical astrocytes, Glia 31 (2000) 249-261.
18. A. Iseki, F. Kambe, K. Okumura, T. Hayakawa, H. Seo, Regulation of thyroid follicular cell function by intracellular redox-active copper, Endocrinology 141 (2000) 4373-4382.
19. S.L. Hempel, M.M. Monick, B. He, T. Yano, G.W. Hunninghake, Synthesis of prostaglandin H synthase-2 by human alveolar macrophages in response to lipopolysaccharide is inhibited by decreased cell oxidant tone, J. Biol. Chem. 269 (1994) 32979-32984.
20. T. Tetsuka, L.D. Baier, A.R. Morrison, Antioxidants inhibit interleukin-1-induced cyclooxygenase and nitric-oxide synthase expression in rat mesangial cells, J. Biol. Chem. 271 (1996) 11689-11693.
21. M.S. Chin, C.N. Nagineni, L.C. Hooper, B. Detrick, J.J. Hooks, Cyclooxygenase-2 gene expression and regulation in human retinal pigment epithelial cells, Invest. Opthalmol. Vis. Sci. 42 (2001) 2338-2346.
22. R. Chinery, R.D. Beauchamp, Y. Shyr, S.C. Kirkland, R.J. Coffey, J.D. Morrow, Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells, Cancer Res. 58 (1998) 2323-2327.
23. T. Kanekura, Y. Higashi, T. Kanzaki, Inhibitory effects of 9-cis-retinoic acid and pyrrolidine dithiocarbamate on cyclooxygenase (COX)-2 expression and cell growth in human skin squamous carcinoma cells, Cancer Lett. 161 (2000) 177-183.
24. G.W. Verhaegh, M. Richard, P. Hainaut, Regulation of p53 by metal ions and by antioxidants: Dithiocarbamate down-regulates p53 DNA-binding activity by increasing the intracellular level of copper, Mol. Cell. Biol. 17 (1997) 5699-5706.
25. C.H. Kim, J.H. Kim, J. Xu, C.Y. Hsu, Y.S. Ahn, Pyrrolidine dithiocarbamate induces bovine cerebral endothelial cell death by increasing the intracellular zinc level, J. Neurochem. 72 (1999) 1586-1592.
26. J.L. Masferrer, B.S. Zweifel, P.T. Manning, S.D. Hauser, K.M. Leahy, W.G. Smith, P.C. Isakson, K. Seibert, Selective inhibition of inducible cyclooxygenase 2 in vivo is antiiflammatory and nonulcerogenic, Proc. Natl. Acad. Sci. USA 91 (1994) 3228-3232.
27. I. Appleton, A. Tomlinson, J.A. Mitchell, D.A. Willoughby, Distribution of cyclooxygenase isoforms in murine chronic granulomatous inflammation. Implications for future anti-inflammatory therapy, J. Pathol. 176 (1995) 413-420.
28. C.D. Klassen, Nonmetallic environmental toxicants: Air pollutions, solvents and vapors, and pesticides, in: A.G. Gilman, T.W. Rall, A.S. Nies, P. Taylor (Eds.), Goodman & Gilman's the Pharmacological Basis of Therapeutics, Pergamon Press, New York, 1990, pp. 1615-1639.
29. L. Feng, Y. Xia, G.E. Garcia, D. Hwang, C.B. Wilson, Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-α, and lipopolysaccharide, J. Clin. Invest. 95 (1995) 1669-1675.
30. T. Nakamura, K. Sakamoto, Reactive oxygen species up-regulates cyclooxygenase-2, p53, and bax mRNA expression in bovine luteal cells, Biochem. Biophys. Res. Commun. 284 (2001) 203-210.